Trop-2 Drug Conjugate May Trump Chemo in HR+, HER2- BRCA
If approved, the ADC would join sacituzumab govitecan (Trodelvy, Gilead) as agents that target trophoblast cell-surface antigen-2 (Trop-2), which is universally expressed in breast cancer.
Stay updated with breaking news from Ron Bose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If approved, the ADC would join sacituzumab govitecan (Trodelvy, Gilead) as agents that target trophoblast cell-surface antigen-2 (Trop-2), which is universally expressed in breast cancer.
Cynthia X. Ma, MD, PhD, discusses updates in triple-negative breast cancer treatment, recent data on HER2-targeted agents in metastatic and early-stage HER2-positive breast cancer, and the role of CDK4/6 inhibitors and oral selective estrogen receptor degraders in hormone receptor–positive disease.
World Health Day: Local man gives thanks to NHS a year on from heart attack April 7 2021, 3.04pm A Fife man has thanked NHS and charity staff to mark World Health Day, a year on from experiencing a heart attack. Ron Bose, from Rosyth, experienced a heart attack in April last year, just after the country went into lockdown due to the coronavirus pandemic. The 77-year-old explains: “I thought myself reasonably healthy. I used to go for daily walks and do plenty of exercise. “In March last year I occasionally felt a tightness in my chest, but it didn’t feel like anything ...